Bio-Rad Laboratories (BIO) 144.90 $BIO Bio-Rad to Report

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bio-Rad Laboratories (BIO) 144.90 $BIO

Bio-Rad to Report Second-Quarter 2016 Financial Results Wednesday, August 3, 2016
Marketwire Canada - Mon Jul 11, 1:03PM CDT
HERCULES, CA--(Marketwired - Jul 11, 2016) - Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO.B) , a global provider of life science research and clinical diagnostic products, will report financial results for the second quarter 2016 on Wednesday, August 3, 2016, following the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Daylight Time (5 PM Eastern Daylight Time) that day.
BIO: 144.90 (+0.98), BIO.B: 141.98 (unch)

Bio-Rad Unveils Amplichek II Quality Control, the First in a Series of Controls for the Molecular Diagnostics Testing Market
Marketwired - Mon May 23, 7:30AM CDT
HERCULES, CA--(Marketwired - May 23, 2016) - Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO.B) , a global provider of life science research and clinical diagnostic products, today announced its entry into the rapidly growing molecular diagnostics testing market with the launch of Amplichek™ II quality control, which was recently issued a de novo clearance from the U.S. Food and Drug Administration (FDA).
BIO: 144.90 (+0.98), BIO.B: 141.98 (unch)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Bio-Rad Laboratories, Inc.
ACCESSWIRE - Mon May 16, 2:25PM CDT
NEW YORK, NY / ACCESSWIRE / May 16, 2016 / Levi & Korsinsky announces it has commenced an investigation of Bio-Rad Laboratories, Inc. (NYSE: BIO) concerning possible breaches of fiduciary duty by the board of directors of the company. To obtain additional information, go to: http://zlk.9nl.com/bio-rad-laboratories or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
BIO: 144.90 (+0.98)

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Bio-Rad Laboratories, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
ACCESSWIRE - Mon May 16, 9:08AM CDT
NEW YORK, NY / ACCESSWIRE / May 16, 2016 / Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Bio-Rad Laboratories, Inc. (NYSE: BIO).
BIO: 144.90 (+0.98)

Bio-Rad posts 1Q profit
Automated Insights - Thu May 05, 4:12PM CDT
HERCULES, Calif. (AP) _ Bio-Rad Laboratories Inc. (BIO.B) on Thursday reported first-quarter profit of $12.3 million.
BIO: 144.90 (+0.98), BIO.B: 141.98 (unch)

Bio-Rad Reports First-Quarter 2016 Currency-Neutral Revenue Growth of Nearly 4 Percent
Marketwire Canada - Thu May 05, 3:16PM CDT
HERCULES, CA--(Marketwired - May 5, 2016) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) , a global provider of life science research and clinical diagnostic products, announced financial results today for the first quarter ended March 31, 2016.
BIO: 144.90 (+0.98), ILMN: 148.99 (+9.35), BIO.B: 141.98 (unch)

Bio-Rad Expands Its Cell Biology Portfolio With High Performance Flow Cytometer
Marketwired - Mon Feb 08, 3:30PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) and Propel Labs today announced that Bio-Rad has acquired a high performance analytical flow cytometer platform from Propel Labs that will enable advanced and novice users to perform basic and multi-parameter cytometry for a wide range of applications and chemistries. Bio-Rad expects to launch the instrument later this year.
BIO: 144.90 (+0.98), BIO.B: 141.98 (unch)

Bio-Rad to Report Fourth-Quarter and Full-Year 2015 Financial Results Thursday, February 25, 2016
Marketwired - Tue Feb 02, 2:36PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO.B) , a global provider of life science research and clinical diagnostic products, will report financial results fourth quarter and full year 2015 on Thursday, February 25, 2016, following the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.
BIO: 144.90 (+0.98), BIO.B: 141.98 (unch)

Fluidigm's Q4 Preliminary Results Fail to Woo Investors
Zacks Equity Research - Zacks Investment Research - Tue Jan 19, 12:40PM CST
Market is not really upbeat about Fluidigm Corporation's (FLDM) preliminary results for the fourth quarter of 2015.
FLDM: 10.08 (+0.11), BIO: 144.90 (+0.98), ILMN: 148.99 (+9.35), EXAC: 27.55 (+0.20)

Bio-Rad Joins Food Safety Consortium With IBM and Mars, Incorporated
Marketwired - Tue Jan 12, 8:30AM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO.B) , a global provider of life science research and clinical diagnostic products, today announced that it has joined the Consortium for Sequencing the Food Supply Chain established in 2015 by scientists from IBM Research (NYSE: IBM) and Mars, Incorporated. The consortium is combining advanced genomics with new informatics tools to observe microbial communities in food and detect hazards in the food supply chain that can threaten safety.
IBM: 157.04 (+1.71), BIO: 144.90 (+0.98), BIO.B: 141.98 (unch)

Bio-Rad and Illumina to Co-Develop Comprehensive Solution for Single-Cell Genomics
BusinessWire - Mon Jan 11, 1:31PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIOb) and Illumina, Inc. (NASDAQ: ILMN) today announced an exclusive partnership to develop the most comprehensive next-generation sequencing (NGS) workflow for single-cell analysis. The end-to-end commercial solution will enable high-throughput sequencing of thousands of individual cells, traditionally a challenging, costly and time-consuming process.
BIO: 144.90 (+0.98), ILMN: 148.99 (+9.35)

Bio-Rad Named One of the 2015 Top 100 Bay Area Innovators by Thomson Reuters
Marketwired - Tue Jan 05, 3:15PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) , a global provider of life science research and clinical diagnostic products, today announced that it was named one of the "Thomson Reuters 2015 Top 100 Bay Area Innovators."
BIO: 144.90 (+0.98), BIO.B: 141.98 (unch)

Bio-Rad's TANGO infinity Receives FDA 510(k) Clearance for U.S. Markets
Marketwired - Mon Dec 21, 3:21PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) , a global provider of life science research and clinical diagnostic products, today announced that it has received U.S. Food and Drug Administration clearance to market its TANGO infinity(R) system in the U.S. The system automates routine blood typing and screening testing procedures for patients and donors.
BIO: 144.90 (+0.98), BIO.B: 141.98 (unch)

FDA Okays Bio-Rad D-100 for HbA1c (Diabetes) Testing
Zacks Equity Research - Zacks Investment Research - Mon Dec 21, 1:25PM CST
Bio-Rad's (BIO) D-100 System delivers rapid high-quality HbA1c testing, without sacrificing the ability to detect hemoglobin variants that can interfere with the interpretation of test results.
CAPR: 4.04 (-0.06), ICUI: 115.22 (-0.52), INSY: 15.16 (-0.02), BIO: 144.90 (+0.98)

10X Genomics Founders Prevail in Dispute with Bio-Rad
BusinessWire - Mon Dec 21, 6:00AM CST
10X Genomics, Inc., today announced that its founders and executive officers, Drs. Serge Saxonov, Benjamin Hindson and Kevin Ness, have unequivocally prevailed in an arbitrated dispute brought against them by Bio-Rad Laboratories, Inc. (NYSE: BIO).
BIO: 144.90 (+0.98)

Bio-Rad Receives FDA Clearance for Its D-100 System for A1c Testing
Marketwired - Wed Dec 16, 5:19PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) , a global provider of life science research and clinical diagnostic products, today announced that its D-100(TM) System for A1c testing has obtained clearance from the U.S. Food and Drug Administration to monitor the long-term blood glucose control of individuals with diabetes, as an aid in the diagnosis of diabetes, and to help identify those who may be at risk for developing the disease.
BIO: 144.90 (+0.98), BIO.B: 141.98 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NOARK: Powering Data Centers with Global-Local Approach

Updated Category News Views 4

The High-Stakes Race for Data Center Power These days, if you're not talking about data centers, you're probably a step behind the curve. AI's explosive growth is pushing data center developments across North America like never before. Larger campuses, hefty power densities—it's all happening at a pace that's got everyone scrambling. For folks like NOARK Electric, this...

Continue Reading
AI Revenue Missteps Shake Semiconductor Stocks

Updated Category News Views 3

Nervous Times for Semiconductor Stocks When the semiconductor sector started October like a high-speed train, I thought we might sail through this month without hitting turbulence. But then, in trotted some shaky AI revenue numbers, and bam, the whole sector took a hit off its October highs. The semiconductor stocks, led by giants like Taiwan Semiconductor Manufacturing...

Continue Reading
RingConn Smart Ring Gains Key FDA 510(k) Clearance

Updated Category News Views 6

FDA Clearance: A Major Step for RingConn In a space where every tiny gadget-maker is desperately clawing for a regulatory nod, RingConn—a venture born from Shenzhen Ninenovo Technology Limited—has snagged an FDA 510(k) clearance (Clearance No. K260490) for their wearable Smart Ring that measures blood oxygen levels non-invasively. October 10, 2026, marked the day when...

Continue Reading
KAPSARC Drives Energy Dialogue at WPC in Riyadh

Updated Category News Views 3

Defining Energy Horizons in Riyadh Mark those calendars, because as the global energy crowd descends on Riyadh from October 11 to 15, 2026, KAPSARC steps into the spotlight. As the National Partner at the 25th World Petroleum Congress (WPC), they're not just warming the bench—they're playing every position, shaking up the field of energy. Paving the Pathways with...

Continue Reading
Buying Land in Greeneville: Avoiding Costly Mistakes

Updated Category News Views 3

Diving Headfirst into Raw Land Purchases Buying land isn't like your typical house flip in Greeneville, Tennessee. It's a whole different ballgame out there. You might think you're just purchasing a piece of Mother Earth, but you got to know there's more beneath the surface—quite literally—before you sign anything. You can go from a promising adventure to a...

Continue Reading
Young Visionaries Win Junior Medals at STARMUS VIII

Updated Category News Views 6

Fresh from the Canary Islands' shores, STARMUS VIII has lifted the veil on two young powerhouses shaping tomorrow—Valeria Corrales and Aneeshwar Kunchala. These two have snagged coveted honors, crowning them as champions of their generation. Igniting Passion for Science and the Environment Valeria Corrales isn't just another face in the crowd; she’s the force behind a...

Continue Reading
Tchah Sup Kim: A Retrospective at KCCNY in 2026

Updated Category News Views 3

A Glimpse into Tchah Sup Kim's Legacy Stumble into the world of Tchah Sup Kim (1940–2022) this fall at the Korean Cultural Center New York. Kim's posthumous retrospective, "The Key to a New World," brings together over 130 of his works alongside archival materials, offering a comprehensive dive into a mind that spent decades between New York and Korea. The exhibit,...

Continue Reading
AI in Music: CITY JAM Focuses on Human Creativity

Updated Category News Views 5

Breaking Down the AI Music Race In the wild world of music production, AI's making waves. Here's the thing though—it's all about how fast and how much it can churn out. Now, won't lie to you, that's impressive, but not the full picture. Pat Villaceran, the brain behind CITY JAM, is adamant that the real gold isn't just speed. It's the unique sound each artist brings to...

Continue Reading
Retail Trading Platforms Report Record Growth in 2026

Updated Category News Views 3

A Boom in Self-Directed Investing Times are changing, folks. More people than ever are taking finance into their own hands, wielding smartphones like fiscal swords in the name of self-directed investment. No middlemen, no fancy office, just straight-up trading from wherever you might be perched. Four major platforms now boast over 41 million funded accounts combined, each...

Continue Reading
tm:rw Revolutionizes Retail with Live TikTok Studios

Updated Category News Views 3

tm:rw Takes a Bold Step into Social Commerce Throw out whatever you've thought about traditional brick-and-mortar retail because tm:rw isn't just bending the rules—it's burning the book. Launching nine branded studio spaces at their Times Square flagship, tm:rw is blending live streaming with in-person shopping, all in sync with TikTok Shop. The experience is less about...

Continue Reading

Top 5 Most Recently Viewed Articles

Private Label MFG Unveils Cutting-Edge Exhaust Systems for Honda

Updated Category News Views 211

Private Label MFG Showcases Exhaust Innovations at SEMA Show Private Label MFG (PLM), known for its high-performance automotive exhaust systems, is excited to announce its debut at the SEMA Show in Las Vegas. This event marks a significant milestone for the company, as it positions itself to expand its market presence. Highlighting the 2025 Honda Civic Type-R Exhaust...

Continue Reading
Incredible Deals and Family Fun Await with Princess Cruises

Updated Category News Views 240

Exciting Perks in the Come Aboard Sale Princess Cruises, renowned for its delightful offerings and family-friendly vacations, has just launched its captivating Come Aboard Sale. This limited-time event provides exceptional savings for travelers seeking the adventure of a lifetime. Offering up to 40% off cruise fares, free room upgrades, and incredibly low deposits...

Continue Reading
Simcere Pharmaceuticals Receives Breakthrough Designation for Stroke Drug

Updated Category News Views 261

Simcere Pharmaceuticals Receives Breakthrough Therapy Designation Simcere Pharmaceuticals Group Ltd. has reached an important milestone, securing the Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for its innovative Sanbexin Sublingual Tablets. This significant medication is designed to treat Acute Ischemic Stroke (AIS), and it's the...

Continue Reading
UBS Announces New Coupon Payment Details for ETRACS ETNs

Updated Category News Views 215

UBS Shares Exciting Updates on ETRACS Exchange Traded Notes UBS Investment Bank has exciting news for investors in its ETRACS Exchange Traded Notes (ETNs). The bank has officially announced coupon payments for several of these instruments traded on leading stock exchanges. Investors are eager to know about coupon payments related to these ETNs, as it directly affects...

Continue Reading
Olive Tree People's Flagship Store Revolutionizes Beauty

Updated Category News Views 556

Olive Tree People Launches Its First US Flagship Store Olive Tree People has emerged as a leader in the evolving waterless beauty industry, marking a significant milestone with the opening of its first flagship store. This innovative brand has gained immense popularity, amassing impressive sales figures that reflect its rapid growth. With over $104 million in sales within...

Continue Reading